TY - JOUR
T1 - Resistance to 1,25-dihydroxyvitamin D3 of a deoxycytidine kinase-deficient variant of human leukemia HL60 cells
AU - Xu, Hui min
AU - Kolla, Sarah S.
AU - Goldenberg, Neil A.
AU - Studzinski, George P.
N1 - Funding Information:
We are grateful to Dr. Kapil Bhalla, Medical University of South Carolina, for the generous gift of HLGO-araC cells, and to Dr. Milan Uskokovich, Hoffmann-LaRoche, for 1,25(OH),D,. This work was supported by USPHS Grant ROl CA 4472204 from the National Cancer Institute, NIH.
PY - 1992/11
Y1 - 1992/11
N2 - A deoxycytidine kinase-deficient variant of HL60 cells (HL60-araC), isolated by its resistance to 1-α-d-arabinofuranosyl cytosine (ara-C), shows cross-resistance to the differentiation-inducing and growth-inhibitory effects of 1,25-dihydroxyvitamin D3 (1,25 (OH)2D3). This is not due to the lack of uptake of 1,25(OH)2D3 by HL60-araC cells, shown by an increased rate of intracellular accumulation of [3H]-1,25(OH)2D3, or to the lack of expression of the gene for the vitamin D3 receptor. However, down-modulation of the expression of this gene by 1,25(OH)2D3 is markedly delayed in HL60-araC cells and the down-regulation of the expression of the c-myc gene is also delayed. In contrast, the expression of the constitutively expressed 16S mitochondrial rRNA gene is unchanged by 1,25(OH)2D3 treatment of either cell subline. These findings suggest that some cases of drug resistance may be associated with defective functioning of a differentiation pathway.
AB - A deoxycytidine kinase-deficient variant of HL60 cells (HL60-araC), isolated by its resistance to 1-α-d-arabinofuranosyl cytosine (ara-C), shows cross-resistance to the differentiation-inducing and growth-inhibitory effects of 1,25-dihydroxyvitamin D3 (1,25 (OH)2D3). This is not due to the lack of uptake of 1,25(OH)2D3 by HL60-araC cells, shown by an increased rate of intracellular accumulation of [3H]-1,25(OH)2D3, or to the lack of expression of the gene for the vitamin D3 receptor. However, down-modulation of the expression of this gene by 1,25(OH)2D3 is markedly delayed in HL60-araC cells and the down-regulation of the expression of the c-myc gene is also delayed. In contrast, the expression of the constitutively expressed 16S mitochondrial rRNA gene is unchanged by 1,25(OH)2D3 treatment of either cell subline. These findings suggest that some cases of drug resistance may be associated with defective functioning of a differentiation pathway.
UR - http://www.scopus.com/inward/record.url?scp=0026459318&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0026459318&partnerID=8YFLogxK
U2 - 10.1016/0014-4827(92)90061-C
DO - 10.1016/0014-4827(92)90061-C
M3 - Article
C2 - 1426045
AN - SCOPUS:0026459318
SN - 0014-4827
VL - 203
SP - 244
EP - 250
JO - Experimental cell research
JF - Experimental cell research
IS - 1
ER -